WorldPingRoche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.
Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.
When each newsroom published on this story, oldest first — all times UTC.
STAT+: Biotech companies are struggling to navigate Trump’s new tariffs
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.
Read the full report at STATLiving hubs that keep updating as this story develops.
WorldPingPhRMA is suing the Trump administration, smaller biotech firms are frustrated over tariffs, and more of the latest pharma news.
Brief by WorldPing · Original reporting by STAT
WorldPingSmaller biotech firms are trying to figure out how to win exemptions from Trump's import taxes.
Brief by WorldPing · Original reporting by STAT
California realtor Wanying Zhang is facing federal prosecution for allegedly surveilling the Taiwanese president's son in Washington last year at the direction of Chinese government officials.
Brief by WorldPing · Original reporting by CBS News
Britain faces a finely balanced choice over whether to follow the EU in imposing tariffs on Chinese EVs.
Brief by WorldPing · Original reporting by CNBC World
WorldPing